Literature DB >> 27217407

Longitudinal Patterns of Blood Pressure, Incident Cardiovascular Events, and All-Cause Mortality in Normotensive Diabetic People.

Zhijun Wu1, Cheng Jin1, Anand Vaidya1, Wei Jin1, Zhe Huang1, Shouling Wu2, Xiang Gao2.   

Abstract

Lower blood pressure (BP) within the normotensive range has been suggested to be deleterious in diabetic people using antihypertensive drugs. We hypothesized that BP <120/80 mm Hg and BP trajectories may predict further risk of all-cause mortality or cardiovascular events in normotensive diabetic individuals. We included 3159 diabetic adults, free of hypertension, atherosclerotic cardiovascular diseases, or cancer in 2006 (baseline), from a community-based cohort including 101 510 participants. A total of 831 participants with BP <120/80 mm Hg and 2328 participants with BP of 120 to 139/80 to 89 mm Hg were included. BP and other clinical covariates were repeatedly measured every 2 years. During 7 years of follow-up, we documented 247 deaths and 177 cardiovascular events. Diabetic people with BP <120/80 mm Hg had a 46% increased risk of all-cause mortality (95% confidence interval, 10%-93%) compared with those with BP of 120 to 139/80 to 89 mm Hg at baseline. We then estimated the association between BP trajectories from 2006 to 2008 and adverse events among 2311 diabetic people who had both BP measures at 2006 and 2008. Relative to stable BP of 120 to 139/80 to 89 mm Hg, having persistently BP <120/80 mm Hg (hazard ratio: 2.35; 95% confidence interval, 1.10-5.01) or a spontaneous decrease in BP from 120 to 139/80 to 89 to <120/80 mm Hg (hazard ratio: 3.04; 95% confidence interval, 1.56-5.92) was significantly associated with an increased risk of all-cause mortality during 2008 to 2014. A rise in BP from 120 to 139/80 to 89 to ≥140/90 mm Hg conferred a high risk of cardiovascular events (hazard ratio: 1.98; 95% confidence interval, 1.24-3.17). In normotensive diabetic people having a low BP or a decline in BP was both associated with an increased risk of all-cause mortality, whereas development of incident hypertension increased the risk of cardiovascular events.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  blood pressure; cardiovascular disease; comorbidity; diabetes mellitus; longitudinal study

Mesh:

Year:  2016        PMID: 27217407      PMCID: PMC4982467          DOI: 10.1161/HYPERTENSIONAHA.116.07381

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  37 in total

1.  AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation.

Authors:  Sidney C Smith; Emelia J Benjamin; Robert O Bonow; Lynne T Braun; Mark A Creager; Barry A Franklin; Raymond J Gibbons; Scott M Grundy; Loren F Hiratzka; Daniel W Jones; Donald M Lloyd-Jones; Margo Minissian; Lori Mosca; Eric D Peterson; Ralph L Sacco; John Spertus; James H Stein; Kathryn A Taubert
Journal:  Circulation       Date:  2011-11-03       Impact factor: 29.690

Review 2.  Diagnosis and management of the cardiac amyloidoses.

Authors:  Rodney H Falk
Journal:  Circulation       Date:  2005-09-27       Impact factor: 29.690

3.  Executive summary: Standards of medical care in diabetes--2014.

Authors: 
Journal:  Diabetes Care       Date:  2014-01       Impact factor: 19.112

Review 4.  Diabetes mellitus and hypertension.

Authors:  M Epstein; J R Sowers
Journal:  Hypertension       Date:  1992-05       Impact factor: 10.190

5.  A prospective follow-up study of the relationship between C-reactive protein and human cancer risk in the Chinese Kailuan Female Cohort.

Authors:  Gang Wang; Ni Li; Sheng Chang; Bryan A Bassig; Lanwei Guo; Jiansong Ren; Kai Su; Fang Li; Shuohua Chen; Shouling Wu; Yuhuan Zou; Min Dai; Tongzhang Zheng; Jie He
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-12-09       Impact factor: 4.254

6.  Ideal cardiovascular health metrics and the risks of ischemic and intracerebral hemorrhagic stroke.

Authors:  Qian Zhang; Yong Zhou; Xiang Gao; Chunxue Wang; Shufeng Zhang; Anxin Wang; Na Li; Liheng Bian; Jianwei Wu; Qian Jia; Shouling Wu; Xingquan Zhao
Journal:  Stroke       Date:  2013-07-18       Impact factor: 7.914

7.  Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.

Authors:  Stevo Julius; Sverre E Kjeldsen; Michael Weber; Hans R Brunner; Steffan Ekman; Lennart Hansson; Tsushung Hua; John Laragh; Gordon T McInnes; Lada Mitchell; Francis Plat; Anthony Schork; Beverly Smith; Alberto Zanchetti
Journal:  Lancet       Date:  2004-06-19       Impact factor: 79.321

8.  Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: the Framingham Study.

Authors:  R B D'Agostino; A J Belanger; W B Kannel; J M Cruickshank
Journal:  BMJ       Date:  1991-08-17

9.  Stroke--1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders.

Authors: 
Journal:  Stroke       Date:  1989-10       Impact factor: 7.914

Review 10.  National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants.

Authors:  Goodarz Danaei; Mariel M Finucane; Yuan Lu; Gitanjali M Singh; Melanie J Cowan; Christopher J Paciorek; John K Lin; Farshad Farzadfar; Young-Ho Khang; Gretchen A Stevens; Mayuree Rao; Mohammed K Ali; Leanne M Riley; Carolyn A Robinson; Majid Ezzati
Journal:  Lancet       Date:  2011-06-24       Impact factor: 79.321

View more
  30 in total

1.  Longitudinal Change of Perceived Salt Intake and Stroke Risk in a Chinese Population.

Authors:  Yun Li; Zhe Huang; Cheng Jin; Aijun Xing; Yesong Liu; Chunmei Huangfu; Alice H Lichtenstein; Katherine L Tucker; Shouling Wu; Xiang Gao
Journal:  Stroke       Date:  2018-05-08       Impact factor: 7.914

2.  A longitudinal study of altered taste and smell perception and change in blood pressure.

Authors:  Y-H Liu; Z Huang; A Vaidya; J Li; G C Curhan; S Wu; X Gao
Journal:  Nutr Metab Cardiovasc Dis       Date:  2018-05-30       Impact factor: 4.222

3.  Smell and Taste Dysfunction Is Associated with Higher Serum Total Cholesterol Concentrations in Chinese Adults.

Authors:  Zhe Huang; Shue Huang; Hongliang Cong; Zheng Li; Junjuan Li; Kathleen L Keller; Gregory C Shearer; Penny M Kris-Etherton; Shouling Wu; Xiang Gao
Journal:  J Nutr       Date:  2017-06-14       Impact factor: 4.798

4.  Sleep and CKD in Chinese Adults: A Cross-Sectional Study.

Authors:  Junjuan Li; Zhe Huang; Jinhong Hou; Amy M Sawyer; Zhijun Wu; Jianfang Cai; Gary Curhan; Shouling Wu; Xiang Gao
Journal:  Clin J Am Soc Nephrol       Date:  2017-04-07       Impact factor: 8.237

Review 5.  Blood pressure management in patients with type 2 diabetes mellitus.

Authors:  Hisashi Kai
Journal:  Hypertens Res       Date:  2017-04-27       Impact factor: 3.872

6.  Prospective Study of Fasting Blood Glucose and Intracerebral Hemorrhagic Risk.

Authors:  Cheng Jin; Guohong Li; Kathryn M Rexrode; Mahmut E Gurol; Xiaodong Yuan; Ying Hui; Chunyu Ruan; Anand Vaidya; Yanxiu Wang; Shouling Wu; Xiang Gao
Journal:  Stroke       Date:  2017-12-11       Impact factor: 7.914

7.  Blood pressure trajectories in relation to cardiovascular mortality: The Rancho Bernardo Study.

Authors:  S M A J Tielemans; J M Geleijnse; G A Laughlin; H C Boshuizen; E Barrett-Connor; D Kromhout
Journal:  J Hum Hypertens       Date:  2017-03-23       Impact factor: 3.012

8.  Different combinations of glucose tolerance and blood pressure status and incident cardiovascular disease and all-cause mortality events.

Authors:  M A Hajebrahimi; S Akbarpour; A Eslami; F Azizi; F Hadaegh
Journal:  J Hum Hypertens       Date:  2017-07-27       Impact factor: 3.012

9.  Early onset of hyperuricemia is associated with increased cardiovascular disease and mortality risk.

Authors:  Lijun Li; Maoxiang Zhao; Chi Wang; Sijin Zhang; Cuijuan Yun; Si Chen; Liufu Cui; Shouling Wu; Hao Xue
Journal:  Clin Res Cardiol       Date:  2021-04-12       Impact factor: 5.460

10.  Longitudinal change in blood pressure is associated with cardiovascular disease mortality in a Chinese cohort.

Authors:  Jin-Hu Fan; Jian-Bing Wang; Shao-Ming Wang; Christian C Abnet; You-Lin Qiao; Philip R Taylor
Journal:  Heart       Date:  2018-04-24       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.